The Hospitalized Patient With Acute HF: How to Prevent VTE?
Target Audience
Learning Objectives
Upon completion of this activity, participants will:
- Have greater competence related to the
- Use of effective strategies to improve VTE prevention in hospitalized patients with heart failure
- 0.25 AMA PRA Category 1 Credit™
- 0.25 Participation
FACULTY
Professor of Medicine
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Professor
Institute for Health Innovations and Outcomes Research
Feinstein Institutes for Medical Research
System Director
Anticoagulation and Clinical Thrombosis, North
Manhasset, New York
Professor of Anesthesiology
Professor of Surgery (Cardiothoracic)
Co-Director, Cardiothoracic RCU
Duke University School of Medicine
Durham, North Carolina
Victor F. Tapson, MD
Professor of Medicine
Director, Clinical Research for the Women's Guild Lung Institute
Director, Venous Thromboembolism and Pulmonary Vascular Disease Research Program
Associate Director, Pulmonary and Critical Care Division
Cedars-Sinai Medical Center
Los Angeles, California
CONTENT REVIEWER
Department of Medicine
Section of Cardiology
University of Chicago Medicine
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Click here to view the activity or if you are logged in click on the "Complete Activity" button!